{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3003"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3003","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"An Ethical Foundation for Genetic Therapy and Gene Editing (CRISPR)","abstract":"There are many steps involved in the process of introducing CRISPR-Cas9 into the current health care system. This dissertation provides an ethical foundation for the uses of CRISPR-Cas9 genetic therapies and editing techniques, which organizations can utilize when implementing these new technologies. Multiple components must be examined, including the practical application of the concept of autonomy, which benefits from the inclusion of personalism and care ethics as it aims to provide a more effective method upholding the right to independent decision-making. In addition to individual considerations, population-based decisions and public health tools are explored, connecting the human right to health care with the challenges that are experienced in implementing an expensive treatment. These considerations are especially important when working with vulnerable populations in research, as well as when genetic therapies are used at the beginning and end of life, when patients can be most at risk. Reflecting on how an organization currently implements new technologies as well as Pre-Implantation Genetic Diagnosis, is immensely useful and can provide further guidelines when considering genetic editing. Taking practical implications into account is crucial so that organizations can begin the process of considering their use of CRISPR-Cas9 and the education of stakeholders. The dissertation also mentions fears about future uses of genetic editing, which could allow individuals to enhance their unborn children and promote transhumanism and eugenics.","abstract_html":"There are many steps involved in the process of introducing CRISPR-Cas9 into the current health care system. This dissertation provides an ethical foundation for the uses of CRISPR-Cas9 genetic therapies and editing techniques, which organizations can utilize when implementing these new technologies. Multiple components must be examined, including the practical application of the concept of autonomy, which benefits from the inclusion of personalism and care ethics as it aims to provide a more effective method upholding the right to independent decision-making. In addition to individual considerations, population-based decisions and public health tools are explored, connecting the human right to health care with the challenges that are experienced in implementing an expensive treatment. These considerations are especially important when working with vulnerable populations in research, as well as when genetic therapies are used at the beginning and end of life, when patients can be most at risk. Reflecting on how an organization currently implements new technologies as well as Pre-Implantation Genetic Diagnosis, is immensely useful and can provide further guidelines when considering genetic editing. Taking practical implications into account is crucial so that organizations can begin the process of considering their use of CRISPR-Cas9 and the education of stakeholders. The dissertation also mentions fears about future uses of genetic editing, which could allow individuals to enhance their unborn children and promote transhumanism and eugenics.","abstract_has_math":false,"creators":["Lukich, Nikolija"],"institution":null,"degree_name":"PhD","degree_level":"One-year Embargo","degree_discipline":"Health Care Ethics","degree_department":null,"school":null,"contributors":["Joris Gielen","Gerard Magill","Peter Ikechukwu Osuji"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:51:32Z","subjects":["Ethics","Genetic Editing","CRISPR","Genetic Therapy","Transhumanism","Bioethics and Medical Ethics"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/1985","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/1985","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3003","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Joris Gielen","Gerard Magill","Peter Ikechukwu Osuji"]},{"key":"dc:creator","label":"Author","values":["Lukich, Nikolija"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2022-05-07T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2021-05-06T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Health Care Ethics"]},{"key":"thesis:degree_level","label":"Degree Level","values":["One-year Embargo"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Ethics","Genetic Editing","CRISPR","Genetic Therapy","Transhumanism","Bioethics and Medical Ethics"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/1985"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["There are many steps involved in the process of introducing CRISPR-Cas9 into the current health care system. This dissertation provides an ethical foundation for the uses of CRISPR-Cas9 genetic therapies and editing techniques, which organizations can utilize when implementing these new technologies. Multiple components must be examined, including the practical application of the concept of autonomy, which benefits from the inclusion of personalism and care ethics as it aims to provide a more effective method upholding the right to independent decision-making. In addition to individual considerations, population-based decisions and public health tools are explored, connecting the human right to health care with the challenges that are experienced in implementing an expensive treatment. These considerations are especially important when working with vulnerable populations in research, as well as when genetic therapies are used at the beginning and end of life, when patients can be most at risk. Reflecting on how an organization currently implements new technologies as well as Pre-Implantation Genetic Diagnosis, is immensely useful and can provide further guidelines when considering genetic editing. Taking practical implications into account is crucial so that organizations can begin the process of considering their use of CRISPR-Cas9 and the education of stakeholders. The dissertation also mentions fears about future uses of genetic editing, which could allow individuals to enhance their unborn children and promote transhumanism and eugenics."]},{"key":"dc:title","label":"Title","values":["An Ethical Foundation for Genetic Therapy and Gene Editing (CRISPR)"]}]}],"canonical_facts":{"dc:contributor":["Joris Gielen","Gerard Magill","Peter Ikechukwu Osuji"],"dc:creator":["Lukich, Nikolija"],"dc:date.available":["2022-05-07T07:00:00Z"],"dc:date.created":["2021-05-06T07:00:00Z"],"dc:description.abstract":["There are many steps involved in the process of introducing CRISPR-Cas9 into the current health care system. This dissertation provides an ethical foundation for the uses of CRISPR-Cas9 genetic therapies and editing techniques, which organizations can utilize when implementing these new technologies. Multiple components must be examined, including the practical application of the concept of autonomy, which benefits from the inclusion of personalism and care ethics as it aims to provide a more effective method upholding the right to independent decision-making. In addition to individual considerations, population-based decisions and public health tools are explored, connecting the human right to health care with the challenges that are experienced in implementing an expensive treatment. These considerations are especially important when working with vulnerable populations in research, as well as when genetic therapies are used at the beginning and end of life, when patients can be most at risk. Reflecting on how an organization currently implements new technologies as well as Pre-Implantation Genetic Diagnosis, is immensely useful and can provide further guidelines when considering genetic editing. Taking practical implications into account is crucial so that organizations can begin the process of considering their use of CRISPR-Cas9 and the education of stakeholders. The dissertation also mentions fears about future uses of genetic editing, which could allow individuals to enhance their unborn children and promote transhumanism and eugenics."],"dc:identifier":["https://dsc.duq.edu/etd/1985"],"dc:language":["English"],"dc:subject":["Ethics","Genetic Editing","CRISPR","Genetic Therapy","Transhumanism","Bioethics and Medical Ethics"],"dc:title":["An Ethical Foundation for Genetic Therapy and Gene Editing (CRISPR)"],"thesis:degree_discipline":["Health Care Ethics"],"thesis:degree_level":["One-year Embargo"],"thesis:degree_name":["PhD"]},"updated_at":"2026-11-19T07:51:32Z"}